WE,COSMAS BIOSCIENCE

WE,COSMAS BIOSCIENCE

CEO

Hojeong Yu Ph.D.

COSMAS BIOSCIENCE is committed to solving the most pressing issues in today’s centralized healthcare system—high costs, long wait times, and limited access.


To overcome these challenges, we are developing an AI-powered, on-device digital healthcare solution that delivers faster, more personalized care directly to individuals.


Our ultra-sensitive, point-of-care multiplex diagnostic platform enables precision medicine and supports daily health management tailored to each person.


By integrating advanced biotechnology, nanotechnology, and information & communication technology, we have created world-class, groundbreaking innovations.

With this foundation, we are pioneering the AI-driven digital healthcare and personalized wellness market, positioning ourselves as a leading force in the industry.


Our mission is clear: to deliver smarter, more precise care that improves lives and makes the world a healthier place.

Education

University of Illinois at Urbana-Champaign

   Electrical and Computer 

   Engineering, PhD (2017)


Yonsei University
   Electrical and Electronic Engineering,  

   MS (2011)


Yonsei University

   Electrical and Electronic Engineering   

   & Physics (Double Major) (2009)

Career

COSMAS Bioscience, CEO 

   (2024~Present)


Gwangju Institute of Science and 

   Technology (GIST),

   Research Professor (2023~2024)


Harvard Medical School, 

   Postdoctoral Research Fellow 

   (2017~2022)


Publications

Fast detection of SARS-CoV-2 RNA via 

   the integration of plasmonic

   thermocycling and fluorescence 

   detection in a portable device, Nat. 

   Biomed. Eng. 4, 1159-1167 (2020)


-  A rapid assay provides on-site

   quantification of tetrahydrocannabinol

   in oral fluid, Sci. Transl. Med. 13, 

   abe2352 (2021)


CEO

Hojeong Yu Ph.D.

COSMAS BIOSCIENCE is committed to solving the most pressing issues in today’s centralized healthcare system—high costs, long wait times, and limited access.


To overcome these challenges, we are developing an AI-powered, 

on-device digital healthcare solution that delivers faster, more personalized care directly to individuals. Our ultra-sensitive, 

point-of-care multiplex diagnostic platform enables precision medicine and supports daily health management tailored to each person.


By integrating advanced biotechnology, nanotechnology, and information & communication technology, we have created

world-class, groundbreaking innovations. With this foundation, we are pioneering the AI-driven digital healthcare and personalized wellness market, positioning ourselves as a leading force in the industry.


Our mission is clear: to deliver smarter, more precise care that improves lives and makes the world a healthier place.


Education

University of Illinois at Urbana-Champaign

   Electrical and Computer Engineering, PhD (2017)


Yonsei University

   Electrical and Electronic Engineering, MS (2011)


Yonsei University

   Electrical and Electronic Engineering & Physics (Double Major) (2009)

Career

COSMAS Bioscience, CEO (2024~Present)


Gwangju Institute of Science and Technology (GIST), Research Professor (2023~2024)


Harvard Medical School, Postdoctoral Research Fellow (2017~2022)


Publications

Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling 

   and fluorescence detection in a portable device, Nat. Biomed. Eng. 4, 1159-1167 (2020)


A rapid assay provides on-site quantification of tetrahydrocannabinol in oral fluid,

   Sci. Transl. Med. 13, abe2352 (2021)